13017 studies found for:    Canada
Show Display Options
Rank Status Study
1 Active, not recruiting Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
Condition: Prostate Cancer
Intervention:
2 Completed
Has Results
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
Condition: Hypertension
Intervention:
3 Completed
Has Results
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
4 Completed Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne
Condition: Acne
Interventions: Drug: Epiduo/Tactuo +  doxycycline 200mg;   Drug: Isotretinoin + vehicle gel
5 Completed
Has Results
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: BI 10773;   Drug: Placebo;   Drug: Sitagliptin 100mg
6 Completed A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Genetic: ONCOTYPEDX Test
7 Terminated Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)
Condition: Atrial Fibrillation
Interventions: Drug: Dronedarone;   Drug: Placebo (for dronedarone)
8 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
9 Completed Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone;   Drug: thalidomide
10 Completed Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: alvocidib
11 Active, not recruiting Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
12 Active, not recruiting
Has Results
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Condition: Breast Cancer
Intervention: Drug: exemestane
13 Completed
Has Results
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention: Procedure: lab draws and imaging
14 Unknown  Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Conditions: Adenocarcinoma of the Colon;   Stage III Colon Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: cetuximab
15 Completed Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program
Condition: Plaque Psoriasis
Intervention:
16 Completed Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
17 Completed Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: muraglitazar
18 Terminated GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Tesaglitazar;   Drug: Pioglitazone
19 Completed LAPLACE-TIMI 57: LDL-C Assessment Wtih PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy
Condition: Hyperlipidemia
Interventions: Biological: evolocumab (AMG 145);   Other: PLACEBO
20 Recruiting Health Education Materials With or Without a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
Conditions: Anxiety Disorder;   Cognitive/Functional Effects;   Colorectal Cancer;   Depression;   Fatigue;   Psychosocial Effects of Cancer and Its Treatment;   Sleep Disorders
Interventions: Behavioral: exercise intervention;   Other: counseling intervention;   Other: educational intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: fatigue assessment and management;   Procedure: quality-of-life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years